Cargando…

Tracking Parkinson’s Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease

BACKGROUND & OBJECTIVES: Cross-sectional magnetic resonance imaging (MRI) suggests that Parkinson’s disease (PD) is associated with changes in cerebral tissue volume, diffusion tensor imaging metrics, and perfusion values. Here, we performed a longitudinal multimodal MRI study—including structur...

Descripción completa

Detalles Bibliográficos
Autores principales: Melzer, Tracy R., Myall, Daniel J., MacAskill, Michael R., Pitcher, Toni L., Livingston, Leslie, Watts, Richard, Keenan, Ross J., Dalrymple-Alford, John C., Anderson, Tim J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694717/
https://www.ncbi.nlm.nih.gov/pubmed/26714266
http://dx.doi.org/10.1371/journal.pone.0143923
_version_ 1782407507045515264
author Melzer, Tracy R.
Myall, Daniel J.
MacAskill, Michael R.
Pitcher, Toni L.
Livingston, Leslie
Watts, Richard
Keenan, Ross J.
Dalrymple-Alford, John C.
Anderson, Tim J.
author_facet Melzer, Tracy R.
Myall, Daniel J.
MacAskill, Michael R.
Pitcher, Toni L.
Livingston, Leslie
Watts, Richard
Keenan, Ross J.
Dalrymple-Alford, John C.
Anderson, Tim J.
author_sort Melzer, Tracy R.
collection PubMed
description BACKGROUND & OBJECTIVES: Cross-sectional magnetic resonance imaging (MRI) suggests that Parkinson’s disease (PD) is associated with changes in cerebral tissue volume, diffusion tensor imaging metrics, and perfusion values. Here, we performed a longitudinal multimodal MRI study—including structural, diffusion tensor imaging (DTI), and perfusion MRI—to investigate progressive brain changes over one year in a group of older PD patients at a moderate stage of disease. METHODS: Twenty-three non-demented PD (mean age (SD) = 69.5 (6.4) years, disease duration (SD) = 5.6 (4.3) years) and 23 matched control participants (mean age: 70.6 (6.8)) completed extensive neuropsychological and clinical assessment, and multimodal 3T MRI scanning at baseline and one year later. We used a voxel-based approach to assess change over time and group-by-time interactions for cerebral structural and perfusion metrics. RESULTS: Compared to controls, in PD participants there was localized grey matter atrophy over time in bilateral inferior and right middle temporal, and left orbito-frontal cortices. Using a voxel-based approach that focused on the centers of principal white matter tracts, the PD and control cohorts exhibited similar levels of change in DTI metrics. There was no significant change in perfusion, cognitive, or motor severity measures. CONCLUSIONS: In a cohort of older, non-demented PD participants, macrostructural MRI detected atrophy in the PD group compared with the control group in temporal and orbito-frontal cortices. Changes in diffusion MRI along principal white matter tracts over one year were found, but this was not differentially affected by PD.
format Online
Article
Text
id pubmed-4694717
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46947172016-01-13 Tracking Parkinson’s Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease Melzer, Tracy R. Myall, Daniel J. MacAskill, Michael R. Pitcher, Toni L. Livingston, Leslie Watts, Richard Keenan, Ross J. Dalrymple-Alford, John C. Anderson, Tim J. PLoS One Research Article BACKGROUND & OBJECTIVES: Cross-sectional magnetic resonance imaging (MRI) suggests that Parkinson’s disease (PD) is associated with changes in cerebral tissue volume, diffusion tensor imaging metrics, and perfusion values. Here, we performed a longitudinal multimodal MRI study—including structural, diffusion tensor imaging (DTI), and perfusion MRI—to investigate progressive brain changes over one year in a group of older PD patients at a moderate stage of disease. METHODS: Twenty-three non-demented PD (mean age (SD) = 69.5 (6.4) years, disease duration (SD) = 5.6 (4.3) years) and 23 matched control participants (mean age: 70.6 (6.8)) completed extensive neuropsychological and clinical assessment, and multimodal 3T MRI scanning at baseline and one year later. We used a voxel-based approach to assess change over time and group-by-time interactions for cerebral structural and perfusion metrics. RESULTS: Compared to controls, in PD participants there was localized grey matter atrophy over time in bilateral inferior and right middle temporal, and left orbito-frontal cortices. Using a voxel-based approach that focused on the centers of principal white matter tracts, the PD and control cohorts exhibited similar levels of change in DTI metrics. There was no significant change in perfusion, cognitive, or motor severity measures. CONCLUSIONS: In a cohort of older, non-demented PD participants, macrostructural MRI detected atrophy in the PD group compared with the control group in temporal and orbito-frontal cortices. Changes in diffusion MRI along principal white matter tracts over one year were found, but this was not differentially affected by PD. Public Library of Science 2015-12-29 /pmc/articles/PMC4694717/ /pubmed/26714266 http://dx.doi.org/10.1371/journal.pone.0143923 Text en © 2015 Melzer et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Melzer, Tracy R.
Myall, Daniel J.
MacAskill, Michael R.
Pitcher, Toni L.
Livingston, Leslie
Watts, Richard
Keenan, Ross J.
Dalrymple-Alford, John C.
Anderson, Tim J.
Tracking Parkinson’s Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease
title Tracking Parkinson’s Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease
title_full Tracking Parkinson’s Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease
title_fullStr Tracking Parkinson’s Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease
title_full_unstemmed Tracking Parkinson’s Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease
title_short Tracking Parkinson’s Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease
title_sort tracking parkinson’s disease over one year with multimodal magnetic resonance imaging in a group of older patients with moderate disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694717/
https://www.ncbi.nlm.nih.gov/pubmed/26714266
http://dx.doi.org/10.1371/journal.pone.0143923
work_keys_str_mv AT melzertracyr trackingparkinsonsdiseaseoveroneyearwithmultimodalmagneticresonanceimaginginagroupofolderpatientswithmoderatedisease
AT myalldanielj trackingparkinsonsdiseaseoveroneyearwithmultimodalmagneticresonanceimaginginagroupofolderpatientswithmoderatedisease
AT macaskillmichaelr trackingparkinsonsdiseaseoveroneyearwithmultimodalmagneticresonanceimaginginagroupofolderpatientswithmoderatedisease
AT pitchertonil trackingparkinsonsdiseaseoveroneyearwithmultimodalmagneticresonanceimaginginagroupofolderpatientswithmoderatedisease
AT livingstonleslie trackingparkinsonsdiseaseoveroneyearwithmultimodalmagneticresonanceimaginginagroupofolderpatientswithmoderatedisease
AT wattsrichard trackingparkinsonsdiseaseoveroneyearwithmultimodalmagneticresonanceimaginginagroupofolderpatientswithmoderatedisease
AT keenanrossj trackingparkinsonsdiseaseoveroneyearwithmultimodalmagneticresonanceimaginginagroupofolderpatientswithmoderatedisease
AT dalrymplealfordjohnc trackingparkinsonsdiseaseoveroneyearwithmultimodalmagneticresonanceimaginginagroupofolderpatientswithmoderatedisease
AT andersontimj trackingparkinsonsdiseaseoveroneyearwithmultimodalmagneticresonanceimaginginagroupofolderpatientswithmoderatedisease